Actively Recruiting

Age: 40Years - 75Years
All Genders
NCT05846620

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Led by Hvidovre University Hospital · Updated on 2025-03-17

50

Participants Needed

1

Research Sites

293 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The overall aim is to to provide a normal material for the composition and spatial heterogeneity of the following in the healthy lung: i) immune cell populations and their activation patterns, ii) the surrounding cytokine-chemokine milieu, including trans-compartmental fluxes of these mediators between the lung and bloodstream, and iii) the lung microbiome. Main hypotheses: * Absolute and relative immune cell counts in bronchoalveolar lavage fluid (BALF) are similar to those previously reported by other methods6,7. * No trans-compartmental flux of cytokines between the lungs and bloodstream is present, but cytokine concentrations (notably IL-6 and IL-8) vary with the immune-cell-microbiome composition. * Immune cell (mainly T cell) activation, differentiation, and gene expression patterns are expected to differ between blood and BALF in a manner that depends on the regional diversity of the pulmonary microbiome.

CONDITIONS

Official Title

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Who Can Participate

Age: 40Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women
  • Age 40 to 75
Not Eligible

You will not qualify if you...

  • Immune deficiency
  • Lung disease
  • Active cancer or infection
  • Absolute contraindications for bronchoscopy including untreated malignant arrhythmia
  • Documented or suspected intracranial hypertension (intracranial pressure 65 > 15 mmHg)
  • One-lung ventilation
  • Severe coagulopathy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hvidovre Hospital, University of Copenhagen

Hvidovre, Denmark, 2650

Actively Recruiting

Loading map...

Research Team

R

Ronni Plovsing, MD, PhD

CONTACT

K

Katrine Schneider, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung | DecenTrialz